Second-line FOLFOX chemotherapy versus active symptom control for advanced biliary tract cancer (ABC-06): a phase 3, open-label, randomised, controlled trial - Lamarca, A; Palmer, D; Wasan, H (Lancet Oncol, 2021)
et al.